Fondaparinux in patients with ST-segment elevation myocardial infarction.
Hartig
Frank
F
Eller
Philipp
P
Pechlaner
Christoph
C
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005170:Factor X / Q000037:antagonists & inhibitors*; D000077425:Fondaparinux; D006470:Hemorrhage / Q000453:epidemiology; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D011134:Polysaccharides / Q000009:adverse effects / Q000627:therapeutic use*; D012306:Risk
D000925:Anticoagulants; D011134:Polysaccharides; D005170:Factor X; D000077425:Fondaparinux